Navigation Links
A Role Model Spouse can Pass on Good Health Habits

A new study has found that good health habits of a person can influence his/her spouse in adopting the same behaviour .

The study, published in the journal Health Services Research, has shown that being a good role model can actually help a spouse take up a healthy lifestyle.

When one spouse quits smoking or drinking, gets a cholesterol screening or rolls up a sleeve for a flu shot, the other spouse is more likely to follow suit, the study suggests.

"We consistently find that when one spouse improves his or her behaviour, the other spouse is likely to do so as well," said study co-author Tracy Falba, Ph.D.

"It isn't clear which spouse drives the change, but it is clear that these things happen together," said Falba, a visiting assistant professor in Duke University's Center for Health Policy, Law and Management.

The study found that a spouse's influence differed depending on the health behaviour. The affect of the positive role model was strongest when it came to smoking and drinking and weaker for things like getting more vigorous exercise and having a cholesterol test.

In the case of flu shots, a spouse's influence can be "quite striking," Falba said. Husbands whose wives start getting the yearly shot have a 60 percent possibility of getting the shot themselves, compared with 21 percent chances among husbands whose wives do not get the shot.

Many studies have shown that a spouse's habits and sometimes even marriage itself can influence individual health behaviours.

Unlike some previous research on positive health behaviour, the new study tracked changes in both spouses at the same time.

The findings could point toward a new approach for doctors looking to improve the health of married patients, Falba said.

"For example, interventions to increase exercise or reduce abusive drinking might provide explicit tips about how to ge
'"/>




Page: 1 2

Related medicine news :

1. Researchers Develop Mouse Model Of Brain Tumor
2. New Model for understanding Tumor Metastasis
3. Mathematical Model Can Now Help Predict Asthma Risk
4. Model Kate Moss - Re-Birth After Humiliation
5. Womens Self-Esteem Not Lowered By Seeing Ultra Thin Models
6. India Can Become A Role Model In Combating HIV Infections
7. Mouse Models To Determine The Cause Of Aggressive Leukemia
8. Aussie Model Macpherson Hated Tall Figure
9. Mouse Model Beneficial to Study of Head and Neck Cancer
10. Tamil Nadu Emerging As Model State In Public Health Care: Governor
11. iSTART Brain Model Reveals the possible Cause of Autism
Post Your Comments:
(Date:9/5/2008)...dy finds sorafenib helps reverse disease resistanc...ept. 5 (HealthDay News) -- The drug sorafenib may ...o anti-hormonal drugs, Georgetown University Medi...en-receptor or progesterone-receptor positive (ER ...ke anti-hormonal medicines, such as aromatase inhi...
(Date:9/5/2008)... New York Fashion Week,s Annual Desti... New York, New York (PRWEB) September 5, 200...r Centers __title__ American Laser], the largest p...e aesthetic services in the U.S., announces sponso... Week. STYLE360, from Sept. 7-10, serves as the a...
(Date:9/4/2008)...3, 2008In a case-control study, the presence of me...h autism and GI disturbances than in children with...d autism onset were unrelated to MMR vaccine timin...lic Library of Science on September 4 ( http://dx...r to the implementation of measles vaccines in 196...
(Date:9/4/2008)...nt stronger labeling about fungal infection risk ...- Federal health authorities have asked the manufa...s to bolster safety warnings on the risk of develo...gs, Humira, Cimzia, Enbrel and Remicade, belong to...ctor alpha blockers (TNF-alpha blockers), which su...
Breaking Medicine News(10 mins):Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
..., is a common problem among critically ill patient...// The condition can be caused by a number of fact...e metabolism, various medications, or even some nu...have shown hyperglycemia can worsen outcomes for p...
...ents lose the ability to do simple mathematical ca...hers conducted a study to look at the association .... The study included 20 patients with Alzheimer’s ... Alzheimer’s disease and nine were diagnosed with ...
...ble ( RGP ) contact lenses can minimize the chance...hers according to a recent study . More than 100 c...About half the group wore RGP lenses, and the othe...o wore the RGPs generally needed about two weeks t...
... stops the growth of the AIDS virus in the blood m...searchers say alpha-1 antitrypsin (AAT) -- a prote...uses from multiplying. In order for cells to grow,...ay the concept is “...kind of like cutting a compu...
Other Medicine News:
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...4 /- Axentis Pharma AG has,initiated ...d tolerability,of a new therapeutic formulation fo...ystic fibrosis patients. The new formulation allow... directly to the site of,infection. The forthcomin...rent doses of the new drug. Initial results are ex...
(Date:9/4/2008)... antiviral activity and favorable safety ... Sept. 4 /- Idenix,Pharmace...l company engaged,in the discovery and development...er infectious diseases, today announced that it ha...IDX899, a non-nucleoside reverse,transcriptase inh...
(Date:9/4/2008)...edule with Two Abstracts Accepted for Presenta...2008, BRIDGEWATER, N.J., Sept. 4 /- ...ceutical company focused on the treatment of,cardi...he appointment of,Peter L. Garrambone, Jr. to the ... career includes more than 50 pharmaceutical,trans...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 2Tempo Participacoes Announces Increase of 34 25 in EBITDA and of 25 25 in Net Revenue for the 1Q08 19574 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 2ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 3ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 4ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 1Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 6
...as--(BUSINESS WIRE)--Jun 11, 2007 - Repros,Therape... findings,from its six month study of Proellex in ...ted in Europe, enrolled 39,premenopausal women and...luded three dose levels of Proellex(TM) as well as...Lucrin(R), a GnRH,agonist also known as Lupron(R) ...
...on of Phase II Study Demonstrates Significant,Addi...NGTON, Mass., June 12, 2007 /PRNewswire-FirstCall/...that results from the,Company,s Phase II EXPRESS t...ttering will be presented today at the 47th annual...(NCDEU), sponsored,by National Institute for Menta...
Other Medicine Technology:Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: